Fishawack News Articles

News

Find out first what Fishawack have been up to and how we’re continuing to grow

Fishawack continues to build best-in-class service offering with Dudnyk acquisition

21st March 2019

Dudnyk leadership team includes Christopher Tobias, PhD, President; Laurie Bartolomeo, EVP, Creative Director; Drew Desjardins, EVP, Chief Strategy Officer; Annemarie Armstrong, EVP, Director of Client Services; John Kemble, EVP, Creative Producer.

Knutsford, England, March 20, 2019—Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries.

Fishawack’s goal is to increase the range of healthcare communications services that it can offer to commercial and medical affairs teams. It now has healthcare creative agencies that span East to West Coast USA and Europe. 

“Dudnyk brings to Fishawack a particular expertise in rare diseases, oncology, and launching breakthrough molecular medicines,” explains Christopher Tobias, President of Dudnyk. “Our seasoned team will complement Fishawack’s already expansive offering, especially in the area of commercial strategy and creative expertise.” 

“Fishawack has wanted to add an East-coast healthcare marketing agency of scale and is pleased to have found that partnership with Dudnyk,” explains Oliver Dennis, CEO of Fishawack Group of Companies. “The leadership at Dudnyk clearly cares about their people, their clients, and the rare disease and oncology patients they serve. The organization’s values are very much aligned with ours.”

Fishawack is a significant provider of healthcare communication services to both medical affairs and marketing teams. Its history of acquisitions is based on the belief that the teams are stronger together than individually. “It’s not just about acquiring,” said Gail Flockhart, Group President, “it’s about making the synergies real, which means connecting talent across the organisation. The best part of every acquisition is discovering what we can learn from each other.”

“Fishawack is unlike traditional networks that make introductions as client needs arise; instead, we form high-performing inter-company business relationships early on,” says Oliver Dennis. “This is important to our clients who depend on continuity of relationships and teams they can depend on. We’re currently undergoing a rebranding of Fishawack that reflects these core beliefs, and we’re looking forward to sharing this with the healthcare marketing community in the near future.”

Fishawack received corporate finance and legal support from Rick Stark and Phil Hall of KPMG and George Danczak and James Finney of Addleshaw Goddard LLP (UK), respectively. Their financial sponsor is LDC. 

For more information about the Fishawack Group, please contact Gail Flockhart, Group President, at gail.flockhart@fishawack.com. For more information about Dudnyk, please contact Christopher Tobias, PhD, President, at ctobias@dudnyk.com.

About the Fishawack Group

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in the UK (Knutsford, Oxford, London, and Brighton), the USA (Philadelphia, PA, and San Diego, CA), Switzerland (Basel), and India (Hyderabad).

Fishawack comprises two international divisions, Fishawack Medical Communications, developing and delivering services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy, and Fishawack Creative, offering strategic planning, creative development, advertising and promotion, and tactical execution.

We have built our reputation on excellence, creativity, and transparency.

About Dudnyk

Independently owned for the past 25 years, Dudnyk is an award-winning, full-service healthcare advertising agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and highly creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries. Dudnyk offers a unique culture, fosters individual career growth, and promotes collaboration among all disciplines. Learn more at dudnyk.com or @DudnykHealth.

Meet the Fishawack Team at EyeForPharma, Barcelona, March 12-14

12th March 2019

MEET the FISHAWACK TEAM at EYEFORPHARMA, Barcelona, March 12-14

Fishawack Group of Companies is delighted to be an exhibit sponsor at this year’s annual pharma summit at EyeforPharma, Barcelona. Gary Lyons, Group Director – Strategy & Innovation, and Gerry Crawford, Vice President – Carling Communications, will be on hand to meet delegates, showcase our expertise across healthcare communications and hear about the latest insights and trends driving up standards in medicine, technology and patient care. In particular we’re delighted to provide an eye-catching audio-visual experience which will entice delegates to unlock the best kept secret in healthcare communications.

As further introduction to Gary and Gerry – meet the team:

Gary has worked in the industry for over 25 years in sales, marketing, agency and consultancy roles – with particular expertise in early pipeline and portfolio communications planning, scientific communication and multichannel strategies. With his finger on the pulse of latest innovations and services, Gary looks forward to meeting industry colleagues and hearing how some of the latest solutions and thinking can address pharma’s challenges today, tomorrow and the “day after tomorrow”.

Gerry is a passionate, brand-centric marketeer who is driven to deliver strategically-robust, commercially-successful, differentiated brands with sparkling, attention-arresting creative solutions for our clients. Online and offline. Internal and external. Global, regional or local. We look to meeting clients and discussing how we create value for their brands by telling authentic, compelling stories that resonate with the relevant target audience.


Day 1 at EyeForPharma, Barcelona:

It’s #ValveDiseaseDay ― Raising Awareness Around the Globe

1st March 2019

Carling Communications and The Fishawack Group of Companies (of which Carling is part) celebrated Heart Valve Disease (HVD) Awareness Day on Friday, Feb 22, 2019 with special pledges. Boxes of heart-shaped paper art were distributed to 5 offices and employees were asked to pledge to raise awareness of heart valve disease. Once signed, the pledge hearts were adhered to a designated “pledge wall” and photographs were shared on social media. More than 100 employees took the awareness pledge.

“Heart disease accounts for I in 4 deaths annually in the US. As many as 11 million Americans have HVD, yet 70% of individuals over 65 know little to nothing about HVD,” said Jackie MacDonald, Carling Account Director. “We are dedicated to raising HVD awareness around the world.”

The goal of HVD Awareness Day is to increase recognition of the specific risks and symptoms of HVD, improve detection and treatment, and ultimately save lives. HVD is a potentially disabling and deadly disease, but available treatments can save lives―making education and awareness particularly important.

“By signing their name to a heart, each employee pledges to help bring attention to heart valve disease, so that more individuals can understand the severity of this disease, and how it can affect their loved ones,” said Lacey Christman, Carling Group Creative Director, and one of the key contributors to this social media initiative. 

 

Fishawack acquires creative consultancy Blue Latitude Health

10th December 2018

The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency.

“In 2016, we set out our vision to form a major new force in the global creative agency space that would make us as strong in the creative arena as we already are in medical communications,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “With three acquisitions in this space in the last 16 months, I think we’ve firmly announced our intention to achieve this goal. We were actively looking for a consultancy that could bring strategic and customer experience expertise to our portfolio and Blue Latitude Health fits perfectly.”

“To enable us to continue to grow and provide existing and future clients with a stronger offering, we needed to find a partner who both shared our values and matched our ambition,” stated Martin Brass, Managing Director of Blue Latitude Health. “We believe we have found this partner in Fishawack.

Fred Bassett, Head of Strategy and Co-founder of Blue Latitude Health, added “We are thrilled to join an organization with the global scale and extended services in medical and scientific communications that Fishawack offers.”

“Many of our clients are wanting a partner that has specialist global capabilities both commercially and medically, and can ensure alignment of communication objectives,” commented Gail Flockhart, Group Managing Director of Fishawack. “Blue Latitude Health has a deep strategic consulting capability and bring us a base in New York City, from which we can continue to expand our East Coast creative and medical communications teams.”

Fishawack received corporate finance and legal support from Rick Stark and Phil Hall of KPMG and George Danczak and James Finney of Addleshaw Goddard LLP (UK), respectively.

Photo: Top row, Dominic Miller, Fred Bassett, Oliver Dennis; Bottom row, Martin Brass, Gail Flockhart.


Fishawack launches new website and introduces new structure for growth

15th November 2018

The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has launched their new website. The revitalized website introduces the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative, as well as providing news, careers, and contact information for the expanding group, complementing Fishawack’s active presence on LinkedIn and Twitter.

Fishawack Medical Communications partners with global and regional pharmaceutical, biotechnology, and medical device clients to develop and deliver services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy.

Fishawack Creative ensures maximum impact for a client from an extensive offering of state-of-the-art services, strategic planning, creative development, brand marketing, and tactical execution. Connecting strategy and creative is the key to brand success and the Fishawack Creative team have demonstrated the effectiveness of this approach on some of the largest brands in the global pharmaceutical marketplace.

“It is great to have a fresh website that showcases our capabilities and better reflects the dynamism of Fishawack as we collaborate with and integrate our new agencies,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “The new two-division structure provides clarity for our clients of the medical communications and creative offerings our expanding teams deliver across the globe.”